MoonLake Immunotherapeutics MLTX Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's total operating expenses?
- MoonLake Immunotherapeutics (MLTX) reported total operating expenses of $70.02M in Q1 2026.
- How has MoonLake Immunotherapeutics's total operating expenses changed year-over-year?
- MoonLake Immunotherapeutics's total operating expenses increased by 47.5% year-over-year, from $47.49M to $70.02M.
- What is the long-term trend for MoonLake Immunotherapeutics's total operating expenses?
- Over 3 years (2022 to 2025), MoonLake Immunotherapeutics's total operating expenses has grown at a 55.5% compound annual growth rate (CAGR), from $65.06M to $244.84M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.